Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Blood Glucose Self-Monitoring | 17 | 2021 | 791 | 3.62 | Why? |
| Insulin Infusion Systems | 12 | 2020 | 256 | 3.55 | Why? |
| Diabetes Mellitus | 26 | 2021 | 8207 | 3.29 | Why? |
| Blood Glucose | 16 | 2021 | 3642 | 2.34 | Why? |
| Equipment and Supplies | 5 | 2020 | 440 | 2.18 | Why? |
| Diabetes Mellitus, Type 1 | 10 | 2019 | 1969 | 2.02 | Why? |
| Insulin | 8 | 2020 | 1316 | 1.63 | Why? |
| Hypoglycemia | 9 | 2021 | 406 | 1.53 | Why? |
| Hypoglycemic Agents | 8 | 2019 | 2165 | 1.37 | Why? |
| Environmental Pollutants | 2 | 2021 | 320 | 1.23 | Why? |
| Computer Security | 2 | 2018 | 408 | 1.01 | Why? |
| Monitoring, Physiologic | 3 | 2020 | 1956 | 1.01 | Why? |
| Ozone | 2 | 2021 | 757 | 0.98 | Why? |
| Hyperglycemia | 4 | 2021 | 1363 | 0.98 | Why? |
| Insulins | 2 | 2019 | 26 | 0.95 | Why? |
| Glycated Hemoglobin A | 6 | 2020 | 1316 | 0.81 | Why? |
| Wildfires | 1 | 2020 | 65 | 0.80 | Why? |
| Insulin Aspart | 1 | 2019 | 4 | 0.80 | Why? |
| Endocrinology | 3 | 2020 | 252 | 0.79 | Why? |
| Device Approval | 1 | 2019 | 93 | 0.73 | Why? |
| Computing Methodologies | 1 | 2017 | 20 | 0.70 | Why? |
| Biomedical Technology | 2 | 2018 | 257 | 0.67 | Why? |
| Internationality | 2 | 2020 | 3297 | 0.67 | Why? |
| Data Accuracy | 2 | 2021 | 715 | 0.65 | Why? |
| Wireless Technology | 1 | 2018 | 180 | 0.63 | Why? |
| Technology Assessment, Biomedical | 1 | 2017 | 106 | 0.62 | Why? |
| Injections, Subcutaneous | 1 | 2018 | 647 | 0.60 | Why? |
| Equipment Failure | 1 | 2017 | 197 | 0.59 | Why? |
| Air Pollutants | 2 | 2021 | 3110 | 0.51 | Why? |
| Mobile Applications | 3 | 2018 | 3032 | 0.50 | Why? |
| Air Pollution | 2 | 2021 | 3504 | 0.47 | Why? |
| Self-Management | 1 | 2017 | 546 | 0.44 | Why? |
| Wearable Electronic Devices | 1 | 2017 | 694 | 0.41 | Why? |
| Pancreas, Artificial | 2 | 2018 | 10 | 0.36 | Why? |
| Diabetes Complications | 4 | 2021 | 2358 | 0.35 | Why? |
| Drug Dosage Calculations | 2 | 2020 | 243 | 0.35 | Why? |
| Hospitals | 4 | 2021 | 11793 | 0.34 | Why? |
| United States Food and Drug Administration | 4 | 2020 | 1276 | 0.33 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2017 | 6166 | 0.32 | Why? |
| Smartphone | 2 | 2018 | 1840 | 0.32 | Why? |
| Periodicals as Topic | 1 | 2019 | 1492 | 0.31 | Why? |
| Pyruvic Acid | 1 | 2005 | 18 | 0.31 | Why? |
| Evidence-Based Medicine | 1 | 2019 | 3228 | 0.30 | Why? |
| Telemedicine | 6 | 2021 | 25032 | 0.29 | Why? |
| Inpatients | 6 | 2020 | 5161 | 0.28 | Why? |
| Research Design | 2 | 2021 | 5830 | 0.28 | Why? |
| Decision Making | 1 | 2019 | 3132 | 0.27 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.27 | Why? |
| Humans | 49 | 2021 | 930598 | 0.25 | Why? |
| Infusions, Subcutaneous | 2 | 2019 | 36 | 0.24 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.24 | Why? |
| Biomedical Research | 2 | 2019 | 5270 | 0.23 | Why? |
| United States Dept. of Health and Human Services | 1 | 2020 | 71 | 0.20 | Why? |
| Monitoring, Ambulatory | 2 | 2021 | 343 | 0.20 | Why? |
| Dosage Forms | 1 | 2019 | 11 | 0.20 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.20 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.19 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.19 | Why? |
| Carbon Monoxide | 1 | 2020 | 167 | 0.19 | Why? |
| Ruthenium Compounds | 1 | 2018 | 1 | 0.19 | Why? |
| Glucose 1-Dehydrogenase | 1 | 2018 | 2 | 0.19 | Why? |
| Flavin-Adenine Dinucleotide | 1 | 2018 | 6 | 0.19 | Why? |
| Internet | 1 | 2017 | 6204 | 0.19 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.18 | Why? |
| Calibration | 2 | 2020 | 307 | 0.18 | Why? |
| Health Policy | 1 | 2019 | 6242 | 0.18 | Why? |
| Microcomputers | 1 | 2018 | 20 | 0.18 | Why? |
| Hematocrit | 1 | 2018 | 107 | 0.18 | Why? |
| Particulate Matter | 2 | 2021 | 3249 | 0.18 | Why? |
| Aspergillus flavus | 1 | 2018 | 51 | 0.18 | Why? |
| Extracellular Fluid | 1 | 2017 | 19 | 0.18 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.18 | Why? |
| Nitrogen Dioxide | 1 | 2021 | 488 | 0.18 | Why? |
| Journal Impact Factor | 1 | 2019 | 134 | 0.18 | Why? |
| Medical Device Legislation | 1 | 2018 | 41 | 0.18 | Why? |
| Diffusion of Innovation | 2 | 2019 | 440 | 0.18 | Why? |
| Excipients | 1 | 2019 | 118 | 0.18 | Why? |
| Double-Blind Method | 3 | 2019 | 5988 | 0.17 | Why? |
| Therapies, Investigational | 1 | 2020 | 235 | 0.17 | Why? |
| Reproducibility of Results | 4 | 2019 | 11304 | 0.17 | Why? |
| Software | 2 | 2020 | 2501 | 0.17 | Why? |
| History, 20th Century | 2 | 2021 | 1282 | 0.17 | Why? |
| Consumer Product Safety | 1 | 2017 | 57 | 0.17 | Why? |
| National Institutes of Health (U.S.) | 1 | 2000 | 443 | 0.16 | Why? |
| Equipment Safety | 1 | 2018 | 167 | 0.16 | Why? |
| Sweat | 1 | 2017 | 127 | 0.16 | Why? |
| United States | 8 | 2020 | 46150 | 0.16 | Why? |
| Administrative Personnel | 1 | 2000 | 326 | 0.16 | Why? |
| Influenza Pandemic, 1918-1919 | 1 | 2021 | 339 | 0.16 | Why? |
| Reagent Strips | 1 | 2016 | 129 | 0.16 | Why? |
| Prediabetic State | 1 | 2018 | 200 | 0.15 | Why? |
| Blood Chemical Analysis | 1 | 2019 | 541 | 0.15 | Why? |
| Peer Review, Research | 1 | 2019 | 407 | 0.15 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.15 | Why? |
| Geography | 1 | 2021 | 1801 | 0.14 | Why? |
| Culture | 1 | 2018 | 370 | 0.14 | Why? |
| Editorial Policies | 1 | 2019 | 408 | 0.14 | Why? |
| Inventions | 1 | 2018 | 372 | 0.13 | Why? |
| California | 1 | 2020 | 2047 | 0.13 | Why? |
| Tears | 1 | 2017 | 400 | 0.13 | Why? |
| Quality Control | 1 | 2017 | 628 | 0.13 | Why? |
| Glucose | 1 | 2017 | 573 | 0.12 | Why? |
| Product Surveillance, Postmarketing | 1 | 2015 | 189 | 0.12 | Why? |
| Serum Albumin | 1 | 2016 | 571 | 0.12 | Why? |
| Equipment Design | 3 | 2018 | 3095 | 0.12 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.12 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.11 | Why? |
| Reference Standards | 1 | 2015 | 1163 | 0.11 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.10 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.09 | Why? |
| Commerce | 1 | 2018 | 1109 | 0.09 | Why? |
| Chloroquine | 2 | 2021 | 3152 | 0.09 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.09 | Why? |
| Venoms | 1 | 2007 | 24 | 0.08 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2019 | 2782 | 0.08 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Prostheses and Implants | 1 | 2005 | 116 | 0.07 | Why? |
| Pharmaceutical Preparations | 1 | 2019 | 1897 | 0.07 | Why? |
| Societies, Medical | 1 | 2021 | 6907 | 0.07 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.07 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Female | 7 | 2020 | 380317 | 0.06 | Why? |
| Point-of-Care Systems | 1 | 2016 | 2955 | 0.06 | Why? |
| Artificial Intelligence | 1 | 2018 | 3543 | 0.06 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.06 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.06 | Why? |
| Biosensing Techniques | 1 | 2016 | 2116 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.06 | Why? |
| Adult | 4 | 2020 | 244371 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Saliva | 1 | 2017 | 4679 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| Male | 6 | 2020 | 367725 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.05 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.05 | Why? |
| Technology | 1 | 2005 | 812 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Electrons | 1 | 2018 | 53 | 0.04 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| Algorithms | 1 | 2015 | 7346 | 0.04 | Why? |
| Social Media | 1 | 2019 | 5798 | 0.04 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.04 | Why? |
| Amino Acid Oxidoreductases | 1 | 2016 | 10 | 0.04 | Why? |
| Computers | 1 | 2018 | 199 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2019 | 15421 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| San Francisco | 1 | 2018 | 711 | 0.04 | Why? |
| Glycation End Products, Advanced | 1 | 2016 | 72 | 0.04 | Why? |
| Electrodes | 1 | 2016 | 203 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Digestive System Diseases | 1 | 2000 | 378 | 0.04 | Why? |
| Protein Engineering | 1 | 2018 | 536 | 0.04 | Why? |
| Aged | 4 | 2020 | 215776 | 0.03 | Why? |
| Peptides | 1 | 2007 | 2513 | 0.03 | Why? |
| Carbon | 1 | 2016 | 269 | 0.03 | Why? |
| Electrochemical Techniques | 1 | 2018 | 406 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Confidentiality | 1 | 2018 | 581 | 0.03 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.03 | Why? |
| Privacy | 1 | 2018 | 636 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Animals | 1 | 2019 | 78931 | 0.02 | Why? |
| United Kingdom | 2 | 2020 | 18046 | 0.02 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.02 | Why? |
| Kidney Diseases | 1 | 2000 | 1434 | 0.02 | Why? |
| Limit of Detection | 1 | 2016 | 2698 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.02 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.02 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.02 | Why? |
| Sulfonylurea Compounds | 1 | 2007 | 79 | 0.02 | Why? |
| Guideline Adherence | 1 | 2019 | 2309 | 0.02 | Why? |
| Insulin-Secreting Cells | 1 | 2007 | 273 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Weight Loss | 1 | 2007 | 826 | 0.01 | Why? |
| Healthcare Disparities | 1 | 2018 | 3893 | 0.01 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.01 | Why? |
| Alanine Transaminase | 1 | 2007 | 1329 | 0.01 | Why? |
| Liver Function Tests | 1 | 2007 | 1325 | 0.01 | Why? |
| Aspartate Aminotransferases | 1 | 2007 | 1394 | 0.01 | Why? |
| Drug Administration Schedule | 1 | 2007 | 2324 | 0.01 | Why? |
| Metformin | 1 | 2007 | 640 | 0.01 | Why? |
| Dose-Response Relationship, Drug | 1 | 2007 | 3776 | 0.01 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.01 | Why? |
| Blood Pressure | 1 | 2007 | 2198 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2007 | 17020 | 0.01 | Why? |
| Obesity | 1 | 2007 | 7388 | 0.00 | Why? |
Klonoff's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(89)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_